We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTRS icon
126
Viatris
VTRS
$20.1B
$88M 0.17%
8,090,176
+5,662,076
+233% +$74.6M
ALLY icon
127
Ally Financial
ALLY
$13.1B
$87.9M 0.17%
2,021,664
+83,173
+4% +$3.93M
PEG icon
128
Public Service Enterprise Group
PEG
$39.8B
$87.7M 0.17%
1,253,140
+1,206,829
+2,606% +$79.9M
XLE icon
129
PUT
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
$87M 0.16%
2,275,400
-83,600
-4% -$2.9M
GLOB icon
130
Globant
GLOB
$1.35B
$87M 0.16%
331,828
-224,449
-40% -$56.9M
AAPL icon
131
PUT
Apple
AAPL
$4.89T
$85.4M 0.16%
489,100
+390,700
+397% +$65.7M
AXTA icon
132
Axalta
AXTA
$7.01B
$85M 0.16%
+3,458,786
New +$96.7M
UBER icon
133
Uber
UBER
$134B
$84.5M 0.16%
2,369,472
-1,155,023
-33% -$41.5M
ARCC icon
134
Ares Capital
ARCC
$13.5B
$84.1M 0.16%
+4,015,857
New +$85.6M
PR
135
Permian Resources
PR
$17.9B
$84.1M 0.16%
10,419,268
+10,414,106
+201,746% +$82.2M
TWST icon
136
Twist Bioscience
TWST
$5.62B
$83.8M 0.16%
1,696,895
+443,347
+35% +$24.6M
OPCH icon
137
Option Care Health
OPCH
$3.4B
$82M 0.16%
2,872,144
-151,463
-5% -$3.8M
GOOG icon
138
CALL
Alphabet (Google) Class C
GOOG
$3.9T
$81.3M 0.15%
582,000
+388,000
+200% +$52.7M
BLDR icon
139
Builders FirstSource
BLDR
$7.84B
$80.5M 0.15%
1,246,826
+857,196
+220% +$62.2M
GOOGL icon
140
PUT
Alphabet (Google) Class A
GOOGL
$3.91T
$80.4M 0.15%
578,000
-58,000
-9% -$7.88M
ACI icon
141
Albertsons Companies
ACI
$5.4B
$80.2M 0.15%
2,412,887
+1,089,612
+82% +$33.9M
BLK icon
142
Blackrock
BLK
$164B
$80.1M 0.15%
104,849
+26,467
+34% +$20.7M
VFC icon
143
VF Corp
VFC
$6.68B
$79.8M 0.15%
+1,404,070
New +$87.1M
ZTO icon
144
ZTO Express
ZTO
$18.2B
$78.7M 0.15%
3,148,008
+1,129,113
+56% +$31.9M
CTAS icon
145
Cintas
CTAS
$82.4B
$78.2M 0.15%
734,856
-455,676
-38% -$44.3M
PLTR icon
146
Palantir
PLTR
$295B
$78.1M 0.15%
+5,686,469
New +$75.8M
KEYS icon
147
Keysight
KEYS
$54.5B
$77.4M 0.15%
489,839
+190,304
+64% +$31.7M
AMGN icon
148
Amgen
AMGN
$203B
$77.4M 0.15%
319,930
+215,015
+205% +$49.4M
MNST icon
149
Monster Beverage
MNST
$91.4B
$76.1M 0.14%
1,904,946
-314,280
-14% -$13.2M
BAC icon
150
Bank of America
BAC
$435B
$75.8M 0.14%
1,839,209
+1,821,798
+10,463% +$82.2M

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.